Norbert Bromet

495 total citations
24 papers, 399 citations indexed

About

Norbert Bromet is a scholar working on Pharmacology, Spectroscopy and Pharmacology. According to data from OpenAlex, Norbert Bromet has authored 24 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 7 papers in Spectroscopy and 6 papers in Pharmacology. Recurrent topics in Norbert Bromet's work include Analytical Chemistry and Chromatography (7 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Diet and metabolism studies (4 papers). Norbert Bromet is often cited by papers focused on Analytical Chemistry and Chromatography (7 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Diet and metabolism studies (4 papers). Norbert Bromet collaborates with scholars based in France and Italy. Norbert Bromet's co-authors include Maguy Bromet-Petit, Roselyne Boulieu, M. Guerret, Carlo Alberto Maggi, Anne Kästner, Claire Boursier-Neyret, Étienne C. Hirsch, Bernard Walther, F. Javoy‐Agid and Marco Criscuoli and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Neuroscience and The American Journal of Medicine.

In The Last Decade

Norbert Bromet

24 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norbert Bromet France 11 82 79 68 67 54 24 399
Ivan Ricordel France 13 81 1.0× 84 1.1× 97 1.4× 30 0.4× 45 0.8× 33 527
Wagdy W. Wahba United States 14 58 0.7× 97 1.2× 107 1.6× 73 1.1× 65 1.2× 28 710
R. A. Clare United Kingdom 10 102 1.2× 143 1.8× 88 1.3× 79 1.2× 40 0.7× 17 606
P. V. Colthup United Kingdom 9 41 0.5× 90 1.1× 44 0.6× 72 1.1× 65 1.2× 9 487
G. Cuisinaud France 14 73 0.9× 110 1.4× 161 2.4× 53 0.8× 23 0.4× 46 608
J. Gaillot France 12 54 0.7× 62 0.8× 162 2.4× 46 0.7× 35 0.6× 31 509
R. Hendriks Belgium 11 39 0.5× 97 1.2× 82 1.2× 50 0.7× 84 1.6× 14 574
Joseph Magluilo United States 14 83 1.0× 105 1.3× 116 1.7× 125 1.9× 71 1.3× 17 671
Paul K. Wilkinson United States 14 84 1.0× 100 1.3× 138 2.0× 136 2.0× 112 2.1× 17 798
D. W. G. Harron United Kingdom 14 22 0.3× 130 1.6× 70 1.0× 47 0.7× 40 0.7× 55 646

Countries citing papers authored by Norbert Bromet

Since Specialization
Citations

This map shows the geographic impact of Norbert Bromet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norbert Bromet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norbert Bromet more than expected).

Fields of papers citing papers by Norbert Bromet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norbert Bromet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norbert Bromet. The network helps show where Norbert Bromet may publish in the future.

Co-authorship network of co-authors of Norbert Bromet

This figure shows the co-authorship network connecting the top 25 collaborators of Norbert Bromet. A scholar is included among the top collaborators of Norbert Bromet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norbert Bromet. Norbert Bromet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Legouffe, Raphaël, Mathieu Gaudin, David Bonnel, et al.. (2018). Biodistribution of polycyanoacrylate nanoparticles encapsulating doxorubicin by Matrix-Assisted Laser Desorption Ionization (MALDI) Mass Spectrometry Imaging (MSI). Journal of Drug Delivery Science and Technology. 47. 55–61. 15 indexed citations
2.
Arbus, Christophe, Amine Benyamina, Pierre‐Michel Llorca, et al.. (2007). Characterization of human cytochrome P450 enzymes involved in the metabolism of cyamemazine. European Journal of Pharmaceutical Sciences. 32(4-5). 357–366. 10 indexed citations
3.
4.
Evangelista, Stefano, et al.. (2000). A Distribution Study with 14C-Otilonium Bromide in The Rat: Evidence for Selective Tropism for Large Intestine after Oral Administration. Drug Metabolism and Disposition. 28(6). 643–647. 29 indexed citations
6.
Bromet, Norbert, et al.. (1999). Determination of melatonin in biological fluids in the presence of the melatonin agonist S 20098: comparison of immunological techniques and GC-MS methods. Journal of Pharmaceutical and Biomedical Analysis. 21(3). 591–601. 43 indexed citations
7.
Bromet-Petit, Maguy, et al.. (1997). Skin distribution of fipronil by microautoradiography following topical administration to the beagle dog. European Journal of Drug Metabolism and Pharmacokinetics. 22(3). 211–216. 29 indexed citations
8.
Bromet, Norbert, et al.. (1997). METABOLISM STUDY OF DIHYDRO-α-ERGOCRYPTINE,9,10−3H(N)] IN RAT AND HUMAN HEPATOCYTE CULTURES AND RAT, MONKEY, AND HUMAN MICROSOMES. American Journal of Therapeutics. 4(9). 291–300. 4 indexed citations
9.
Thénot, Jean‐Paul, et al.. (1995). A Noncompettive Enzyme Immunoassay for Rat Prolactin. Journal of Immunoassay. 16(1). 81–96. 2 indexed citations
10.
Kästner, Anne, Philippe Anglade, Philippe Damier, et al.. (1994). Immunohistochemical study of catechol-O-methyltransferase in the human mesostriatal system. Neuroscience. 62(2). 449–457. 47 indexed citations
11.
Grislain, L., et al.. (1990). The metabolic pathways of tianeptine, a new antidepressant, in healthy volunteers.. Drug Metabolism and Disposition. 18(5). 804–808. 20 indexed citations
12.
Grislain, L., et al.. (1990). Metabolism of amineptine in rat, dog and man. European Journal of Drug Metabolism and Pharmacokinetics. 15(4). 339–345. 6 indexed citations
13.
Padieu, P, et al.. (1989). Gas chromatographic-mass spectrometric assessment of the pharmacokinetics of amineptine and its main metabolite in volunteers with liver impairment. Journal of Chromatography B Biomedical Sciences and Applications. 487(2). 313–329. 7 indexed citations
14.
Bromet, Norbert, et al.. (1989). Pharmacokinetics of rilmenidine. The American Journal of Medicine. 87(3). S18–S23. 6 indexed citations
15.
Bromet, Norbert, et al.. (1988). Pharmacokinetics of rilmenidine in healthy subjects. The American Journal of Cardiology. 61(7). D47–D53. 11 indexed citations
16.
Guillouzo, A., L. Grislain, Damrong Ratanasavanh, et al.. (1988). Use of hepatocyte cultures for preliminary metabolism and cytotoxicity studies of a new anti-hypertensive agent, oxaminozoline. Xenobiotica. 18(6). 757–763. 4 indexed citations
17.
Bromet, Norbert, et al.. (1983). Pharmacokinetics of almitrine bismesylate: studies in patients.. PubMed. 126. 363–75. 6 indexed citations
18.
Bromet, Norbert, et al.. (1981). Trace determination of trimetazidine in plasma by high-performance liquid chromatography using fluorescence detection. Journal of Chromatography B Biomedical Sciences and Applications. 224(1). 162–167. 25 indexed citations
19.
Bromet, Norbert, et al.. (1981). Trace determination of almitrine in plasma by gas—liquid chromatography using a nitrogen—phosphorus detector. Journal of Chromatography B Biomedical Sciences and Applications. 223(1). 219–224. 19 indexed citations
20.
Bromet, Norbert, et al.. (1980). [Pharmacokinetics of almitrine].. PubMed. 8(6). 569–76. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026